IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-1.15%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$320M
AUM Growth
+$320M
(-13%)
Cap. Flow
+$6.14M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
52.44%
Holding
116
New
16
Increased
13
Reduced
23
Closed
13
Top Buys
| 1 |
Enliven Therapeutics
ELVN
|
$13.7M |
| 2 |
Amgen
AMGN
|
$12M |
| 3 |
Sarepta Therapeutics
SRPT
|
$8.11M |
| 4 |
Viking Therapeutics
VKTX
|
$7.33M |
| 5 |
Cartesian Therapeutics
RNAC
|
$6.55M |
Top Sells
| 1 |
Corbus Pharmaceuticals
CRBP
|
$11.3M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$10.4M |
| 3 |
Praxis Precision Medicines
PRAX
|
$10.3M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$7.7M |
| 5 |
Annexon
ANNX
|
$5.02M |
Sector Composition
| 1 | Healthcare | 99.74% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nuvation Bio
NUVB
$1.08B
| $1.05M | 0.18% |
358,282
-275,000
| -43% | -$803K |
|
|
TECX
52
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $1.03M | 0.18% |
62,836
-691,225
| -92% | -$33 |
|
53
Ventyx Biosciences
VTYX
$184M
| $1.02M | 0.18% |
442,647
-65,000
| -13% | -$150K |
|
|
ALLK
54
DELISTED
Allakos
ALLK
| $973K | 0.17% |
972,675
+40,000
| +4% | +$40K |
|
55
MacroGenics
MGNX
$121M
| $850K | 0.15% |
200,079
-118,088
| -37% | -$502K |
|
56
Delcath Systems
DCTH
$381M
| $840K | 0.15% |
+100,370
| New | +$840K |
|
|
MRNS
57
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $826K | 0.14% |
706,154
+168,229
| +31% | +$197K |
|
58
ProQR Therapeutics
PRQR
$256M
| $803K | 0.14% |
483,583
| – | – |
|
59
Veru
VERU
$48.5M
| $796K | 0.14% |
946,382
| – | – |
|
60
Lyell Immunopharma
LYEL
$220M
| $763K | 0.13% |
+526,066
| New | +$763K |
|
|
CLYM
61
Climb Bio, Inc. Common Stock
CLYM
$165M
| $711K | 0.12% |
+100,000
| New | +$711K |
|
62
Avalo Therapeutics
AVTX
$139M
| $682K | 0.12% |
54,730
+8,082
| +17% | +$101K |
|
63
Acumen Pharmaceuticals
ABOS
$84.2M
| $645K | 0.11% |
266,435
| – | – |
|
64
Milestone Pharmaceuticals
MIST
$151M
| $620K | 0.11% |
466,019
| – | – |
|
|
JBIO
65
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $611K | 0.11% |
367,965
| – | – |
|
66
Immatics
IMTX
$662M
| $574K | 0.1% |
49,415
| – | – |
|
67
Immunic
IMUX
$79.4M
| $548K | 0.1% |
493,496
-1,118,882
| -69% | -$1.24M |
|
68
Amylyx Pharmaceuticals
AMLX
$877M
| $522K | 0.09% |
274,551
-56,900
| -17% | -$108K |
|
69
Kezar Life Sciences
KZR
$28.5M
| $521K | 0.09% |
868,992
| – | – |
|
70
RAPT Therapeutics
RAPT
$187M
| $472K | 0.08% |
154,625
| – | – |
|
71
Voyager Therapeutics
VYGR
$204M
| $442K | 0.08% |
55,857
-125,000
| -69% | -$989K |
|
72
Anebulo Pharmaceuticals
ANEB
$101M
| $431K | 0.08% |
157,862
| – | – |
|
73
Sensei Biotherapeutics
SNSE
$10.9M
| $403K | 0.07% |
+650,000
| New | +$403K |
|
74
Protara Therapeutics
TARA
$125M
| $376K | 0.07% |
180,712
-21,989
| -11% | -$45.7K |
|
|
NYXH
75
Nyxoah
NYXH
$220M
| $357K | 0.06% |
50,699
| – | – |
|